Chronic diseases of agingDisease1 paperLatestNov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 2Sep 2026: 2Oct 2026: 04QeiosIn silicoPreprint·24 SepSteeraMed: A Biomedical World Model for N-of-1 Intervention Reasoning Across Chronic Diseases and AgingAI & dataCardiovascular Diabetology Endocrinology ReportsHumans·22 SepPhenotypic age metrics for risk stratification of chronic disease burden and all-cause mortality in adultsBiomarkersQeiosIn silicoPreprint·30 AugSteeraMed: A Biomedical World Model for N-of-1 Intervention Reasoning Across Chronic Diseases and AgingAI & dataImmunological ReviewsReview·24 AugB1 Cells for LifeMechanismsGSA 2024 AbstractHuman trial·1 JanPRELIMINARY EFFICACY OF AN OT INTERVENTION TO PREVENT FUNCTIONAL DECLINE AMONG OLDER ADULTS WITH CHRONIC DISEASESInterventionsGSA 2024 AbstractReview·1 JanBASIC AND CLINICAL ASPECTS OF VASCULAR AGINGIndustry & policyGSA 2024 AbstractReview·1 JanASSESSING GEROTHERAPEUTIC POTENTIAL OF GLP-1 RECEPTOR AGONISTSInterventions
QeiosIn silicoPreprint·24 SepSteeraMed: A Biomedical World Model for N-of-1 Intervention Reasoning Across Chronic Diseases and AgingAI & data
Cardiovascular Diabetology Endocrinology ReportsHumans·22 SepPhenotypic age metrics for risk stratification of chronic disease burden and all-cause mortality in adultsBiomarkers
QeiosIn silicoPreprint·30 AugSteeraMed: A Biomedical World Model for N-of-1 Intervention Reasoning Across Chronic Diseases and AgingAI & data
GSA 2024 AbstractHuman trial·1 JanPRELIMINARY EFFICACY OF AN OT INTERVENTION TO PREVENT FUNCTIONAL DECLINE AMONG OLDER ADULTS WITH CHRONIC DISEASESInterventions
GSA 2024 AbstractReview·1 JanASSESSING GEROTHERAPEUTIC POTENTIAL OF GLP-1 RECEPTOR AGONISTSInterventions